Clinical Trial Update: To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD [Phase 3]

View source ↗

Summary

Phase 3 study assessing long-term safety of (R,R)-formoterol in COPD subjects has completed; detailed results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• (R,R)-Formoterol (R,R-formoterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Chronic Obstructive Pulmonary Disease, Chronic Bronchitis | Phase 3 | Status: COMPLETED